IL2 and neoplasm: Studies have found that DC vaccine induces anti-tumor immunity by the following mechanism: on the premise of exosomal CD80 stimulation and IL-2 secretion, the exosomal peptide MHCI begins to express, which transmits signals to CD8+ T cells to activate cell proliferation, thus inducing efficient anti-tumor immunity (2).